- EPA Finalizes Rule to Require Removal of Lead Pipes in U.S. Water System
- CDC Will Test Travelers From Rwanda for Ebola-Like Marburg Virus
- Scientists Discover the Brain’s Waste-Disposal System, With Clues to Alzheimer’s Disease
- Were FDA’s ‘Black Box’ Warnings on Antidepressants a Mistake? Youth Suicides Rose Afterwards
- Breast Cancer Treatments Might Speed Aging, Study Finds
- Damage to Brainstem Could Be Driving Long COVID
- Could Music Lessons Help Clear the ‘Brain Fog’ of Chemotherapy?
- New Hope Against Breast Cancers That Spread to the Brain
- AI May Not Be Ready to Run Emergency Rooms
- Epinephrine: Tips to the ‘EpiPen’ Ingredient and How It Treats Anaphylaxis
Health Highlights: Aug. 8, 2019
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Medicare to Cover Breakthrough Gene Therapy for Leukemia, Lymphoma
A breakthrough gene therapy will be covered for certain types of lymphoma and leukemia, Medicare says.
The therapy, called CAR-T, boosts a patient’s own immune cells to fight cancer and can cost hundreds of thousands of dollars, the Associated Press reported.
Studies have shown that CAR-T is effective against certain types of cancers, but can cause severe side effects. The use of the gene therapy to treat certain types of leukemia and lymphoma is approved by the U.S. Food and Drug Administration.
Medicare considered the matter for months before it announced its decision on Wednesday. The agency’s policies on coverage can influence private insurance, the AP reported.
Copyright © 2024 HealthDay. All rights reserved.